Baku and Tbilisi discussed issue of investment in the reconstruction of Georgia's highways

Baku and Tbilisi discussed issue …

Baku and Tbilisi discu...

Pentagon chief left Georgia

Pentagon chief left Georgia

Deputy Defense Ministe...

Georgian parliament begins debate of the draft bill "On the State Language"

Georgian parliament begins debate…

Parliament begins deba...

"Dnepravia" suspends flights from Kharkiv to Tbilisi and Batumi

"Dnepravia" suspends fl…

Airline "Dniproavia" f...

Georgian Orthodox Church celebrates the Assumption of the Blessed Virgin Mary - Mariamoba

Georgian Orthodox Church celebrat…

Georgian Orthodox Chur...

The Georgian Foreign Ministry published a list of countries with which it will support the visa-free message

The Georgian Foreign Ministry pub…

The Georgian Foreign M...

Visa to Georgia will cost $ 50

Visa to Georgia will cost $ 50

From September 1, 2014...

Georgia does not acknowledge presidential elections in Abkhazia

Georgia does not acknowledge pres…

The Georgian Foreign M...

In Baku is discussed the construction of the railway Marabda-Kartsakhi

In Baku is discussed the construc…

The 20th meeting of th...

Azerbaijan, Turkey and Georgia will hold joint military exercises

Azerbaijan, Turkey and Georgia wi…

Azerbaijan, Turkey and...

Prev Next

Genomma Lab Announces Its 2010 Earnings Guidance

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company") announces today its 2010 earnings guidance.

Genomma Lab expects net sales growth in the range of 42% to 45% for the full year of 2010, excluding possible acquisitions, and an EBITDA margin between 25.0% and 26.0%, from 2009 year-end results which we expect to be above our last issued guidance.

The Company's estimates are based on organic growth in base line products, the full year effect in sales of products launched or acquired during 2009, growth in international operations as well as product line extensions and new brands in existing and new categories.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growing pharmaceutical and personal care products companies in Latin America. Genomma Lab develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. The Company has a sound business model through a unique combination of a new product development process, consumer oriented marketing, a broad retail distribution network and a low-cost, highly flexible supply chain operating model.

Contact: Oscar Villalobos
Tel: +52 (55) 5081- 0000 ext. 4250
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

In New York: i-advize Corporate Communications, Inc.
Tel: (212) 406-3695
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

SOURCE Genomma Lab Internacional, S.A.B. de C.V.

Last modified onSaturday, 20 August 2011 00:31

Media

back to top

Share